JP2023542945A5 - - Google Patents

Info

Publication number
JP2023542945A5
JP2023542945A5 JP2023518358A JP2023518358A JP2023542945A5 JP 2023542945 A5 JP2023542945 A5 JP 2023542945A5 JP 2023518358 A JP2023518358 A JP 2023518358A JP 2023518358 A JP2023518358 A JP 2023518358A JP 2023542945 A5 JP2023542945 A5 JP 2023542945A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
optionally substituted
compound according
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023518358A
Other languages
English (en)
Japanese (ja)
Other versions
JP7844452B2 (ja
JP2023542945A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/051403 external-priority patent/WO2022066678A1/en
Publication of JP2023542945A publication Critical patent/JP2023542945A/ja
Publication of JP2023542945A5 publication Critical patent/JP2023542945A5/ja
Application granted granted Critical
Publication of JP7844452B2 publication Critical patent/JP7844452B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023518358A 2020-09-23 2021-09-22 Tesベースのカチオン性脂質 Active JP7844452B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063082090P 2020-09-23 2020-09-23
US63/082,090 2020-09-23
PCT/US2021/051403 WO2022066678A1 (en) 2020-09-23 2021-09-22 Tes-based cationic lipids

Publications (3)

Publication Number Publication Date
JP2023542945A JP2023542945A (ja) 2023-10-12
JP2023542945A5 true JP2023542945A5 (cg-RX-API-DMAC10.html) 2024-10-01
JP7844452B2 JP7844452B2 (ja) 2026-04-13

Family

ID=78179524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518358A Active JP7844452B2 (ja) 2020-09-23 2021-09-22 Tesベースのカチオン性脂質

Country Status (11)

Country Link
US (1) US12655095B2 (cg-RX-API-DMAC10.html)
EP (1) EP4217340A1 (cg-RX-API-DMAC10.html)
JP (1) JP7844452B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230092914A (cg-RX-API-DMAC10.html)
CN (1) CN116507606B (cg-RX-API-DMAC10.html)
AU (1) AU2021347814A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023005269A2 (cg-RX-API-DMAC10.html)
CA (1) CA3193340A1 (cg-RX-API-DMAC10.html)
IL (1) IL301540A (cg-RX-API-DMAC10.html)
MX (1) MX2023003345A (cg-RX-API-DMAC10.html)
WO (1) WO2022066678A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3215606A1 (en) * 2021-04-19 2022-10-27 Shrirang KARVE Improved compositions for delivery of mrna
TW202438514A (zh) 2022-12-20 2024-10-01 法商賽諾菲公司 鼻病毒mrna疫苗
CN117986153B (zh) * 2023-09-07 2026-06-19 晟迪生物医药(苏州)有限公司 一种可电离阳离子脂质化合物及其制备方法和应用
WO2026008743A1 (en) 2024-07-02 2026-01-08 Sanofi Pasteur Inc. Water-soluble polyanionic polymer as adjuvant for carrier-formulated nucleic acid
WO2026052114A1 (zh) * 2024-09-09 2026-03-12 北京科兴中维生物技术有限公司 脂质纳米颗粒及其应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
EP0490919B1 (en) * 1989-08-29 2001-01-17 Virginia Commonwealth University Cytoprotective compounds bearing unsaturated hydrocarbon groups having 16 to 20 carbon atoms
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5780014A (en) 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US6274748B1 (en) 1999-04-14 2001-08-14 Zenith Cosmetic Technologies Llc Process for the manufacture of compounds containing a fatty acid moiety
US7504506B2 (en) 2003-11-04 2009-03-17 Elixir Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
US20100055168A1 (en) 2008-04-16 2010-03-04 Abbott Laboratories Cationic lipids and uses thereof
KR20220038506A (ko) 2009-06-10 2022-03-28 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
WO2014028487A1 (en) 2012-08-13 2014-02-20 Massachusetts Institute Of Technology Amine-containing lipidoids and uses thereof
EP3574923A1 (en) 2013-10-22 2019-12-04 Translate Bio, Inc. Mrna therapy for phenylketonuria
US10059655B2 (en) 2013-12-19 2018-08-28 Novartis Ag Lipids and lipid compositions for the delivery of active agents
KR102559979B1 (ko) 2014-06-24 2023-07-25 샤이어 휴먼 지네틱 테라피즈 인크. 핵산의 전달용 입체화학적으로 풍부한 조성물
CN114656378A (zh) * 2016-05-16 2022-06-24 得克萨斯州大学系统董事会 阳离子磺酰胺氨基脂质和两亲性两性离子氨基脂质
GB201614120D0 (en) 2016-08-18 2016-10-05 Univ Of Kwazulu-Natal pH-responsive lipids
US20180153822A1 (en) 2016-11-10 2018-06-07 Translate Bio, Inc. Process of Preparing mRNA-Loaded Lipid Nanoparticles
TWI802627B (zh) 2017-12-28 2023-05-21 日商武田藥品工業股份有限公司 陽離子性脂質
WO2020032184A1 (ja) 2018-08-10 2020-02-13 武田薬品工業株式会社 カチオン性脂質
KR102860605B1 (ko) 2018-11-09 2025-09-15 트랜슬레이트 바이오 인코포레이티드 에스테르, 티오에스테르, 이황화물, 및 무수물 모이어티가 삽입된 2,5-디옥소피페라진
KR102198736B1 (ko) 2020-01-15 2021-01-05 이화여자대학교 산학협력단 생체 내 약물 전달을 위한 지질 나노입자 및 이의 용도
WO2021226463A1 (en) 2020-05-07 2021-11-11 Translate Bio, Inc. Composition and methods for treatment of primary ciliary dyskinesia
WO2021226468A1 (en) 2020-05-07 2021-11-11 Translate Bio, Inc. Improved compositions for cftr mrna therapy
WO2022066916A1 (en) 2020-09-23 2022-03-31 Translate Bio, Inc. Piperazine-based cationic lipids

Similar Documents

Publication Publication Date Title
JP2023542944A5 (cg-RX-API-DMAC10.html)
JP2023527575A5 (cg-RX-API-DMAC10.html)
JP2023520047A5 (cg-RX-API-DMAC10.html)
JP2005511699A5 (cg-RX-API-DMAC10.html)
JP2023551058A5 (cg-RX-API-DMAC10.html)
JP2022520061A5 (cg-RX-API-DMAC10.html)
JP2005516067A5 (cg-RX-API-DMAC10.html)
JP2006507265A5 (cg-RX-API-DMAC10.html)
JP2024546431A5 (cg-RX-API-DMAC10.html)
JP2002539128A5 (cg-RX-API-DMAC10.html)
JP2011511073A5 (cg-RX-API-DMAC10.html)
JP2005519908A5 (cg-RX-API-DMAC10.html)
JP2004514663A5 (cg-RX-API-DMAC10.html)
JP2006151984A5 (cg-RX-API-DMAC10.html)
JP2011509309A5 (cg-RX-API-DMAC10.html)
JP2025509507A5 (cg-RX-API-DMAC10.html)
JP2008508214A5 (cg-RX-API-DMAC10.html)
JP2019515908A5 (cg-RX-API-DMAC10.html)
CN111012914A (zh) 治疗肺部疾病的高穿透力前药组合物和医药组合物
JP2004500355A5 (cg-RX-API-DMAC10.html)
JP2020505354A5 (cg-RX-API-DMAC10.html)
JP2021534160A5 (cg-RX-API-DMAC10.html)
JP2006525368A5 (cg-RX-API-DMAC10.html)
RU2003131970A (ru) Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
JP2023546316A5 (cg-RX-API-DMAC10.html)